Latest Breaking News On - Pyxis oncology - Page 10 : comparemela.com

Pyxis Oncology Announces Appointment of Ken Kobayashi, M D , F A C P as Chief Medical Officer

Dr. Kobayashi brings over 25 years of experience in oncology drug development, including Antibody Drug Conjugates and other oncology modalitiesBOSTON, Nov. 28, 2023 Pyxis Oncology, Inc. , a.

United statesNorthwestern university medical schoolKen kobayashiDaiichi sankyoLaras sullivanPamela connealyWashington universityClinical development at kinnate biopharmaNational cancer instituteDrug administrationPyxis oncology incExchange commissionAntibody drug conjugatesChief medical officerPyxis oncologyChief executive officer

Form 8-K Pyxis Oncology, Inc For: Nov 27

Form 8-K Pyxis Oncology, Inc For: Nov 27
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNorthwestern university medical schoolWashington universityPamela connealyKen kobayashiDaiichi sankyoClinical developmentCompany board of directorsClinical researchSmall woods biopharma consultingCompany the employment agreementNational cancer instituteGlobal oncology researchCommission file numberEarly oncology developmentCompany registration statement on form

Pyxis Oncology (PYXS) Announces Appointment of Ken Kobayashi, M D , F A C P as Chief Medical Officer

Pyxis Oncology (PYXS) Announces Appointment of Ken Kobayashi, M D , F A C P as Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNorthwestern university medical schoolLaras sullivanKen kobayashiDaiichi sankyoPyxis oncology incClinical development at kinnate biopharmaDrug administrationWashington universityNational cancer institutePyxis oncologyChief medical officerChief executive officerLatin americaSenior vice presidentClinical development

Regeneron stays out of ADC deal fray as scientists tinker

Regeneron stays out of ADC deal fray as scientists tinker
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Richard gonzalezDaiichi sankyoSusan galbraithMerck coBristol myers squibbIsrael lowyEuropean societyMedical oncologyPyxis oncologyFierce biotech

William Blair Reaffirms Outperform Rating for Pyxis Oncology (NASDAQ:PYXS)

William Blair restated their outperform rating on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a research note released on Wednesday morning, RTT News reports. Separately, Royal Bank of Canada started coverage on shares of Pyxis Oncology in a research note on Tuesday, September 5th. They issued an outperform rating and a $7.00 price […]

Nova scotiaKlara sullivanWilliam blairCitadel advisorsPyxis oncology incVanguard group incRoyal bankBlackrock incTower research capitalPrelude capital managementPyxis oncologyFree reportGet free reportResearch capitalPyxis oncology dailyNasdaq pyxs